Three novel pentavalent meningococcal vaccines.

Gonorrhoea Invasive meningococcal disease MenABCWY Meningitis Neisseria meningitidis Travel Vaccination

Journal

Journal of travel medicine
ISSN: 1708-8305
Titre abrégé: J Travel Med
Pays: England
ID NLM: 9434456

Informations de publication

Date de publication:
25 Nov 2023
Historique:
medline: 26 11 2023
pubmed: 26 11 2023
entrez: 25 11 2023
Statut: aheadofprint

Résumé

Invasive meningococcal disease (IMD) is rare in travellers but associated with high mortality and long-term sequelae. Six serogroups (MenABCWXY) account for more than 90% of IMD. Three pentavalent vaccines are on the horizon: two MenABCWY, both with a 0-6 months schedule highly immunogenic and well tolerated, and one single-dose MenACWXY.

Identifiants

pubmed: 38006362
pii: 7451060
doi: 10.1093/jtm/taad152
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of International Society of Travel Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Robert Steffen (R)

Epidemiology, Biostatistics and Prevention Institute, Department of Public and Global Health, Division of Infectious Diseases, World Health Organization Collaborating Centre for Travelers' Health, University of Zurich, Switzerland.
Division of Epidemiology, Human Genetics & Environmental Sciences, University of Texas School of Public Health, Houston, TX, U.S.A.

Eric Caumes (E)

Infectious and Tropical Diseases, Sorbonne University, Paris, France.
Centre de diagnostic et de thérapeutique, Hôpital de l'Hôtel-Dieu. Paris, France.

Classifications MeSH